期刊
CELL STEM CELL
卷 7, 期 6, 页码 682-693出版社
CELL PRESS
DOI: 10.1016/j.stem.2010.11.013
关键词
-
资金
- Prostate Cancer Foundation
- California Institute for Regenerative Medicine [T1-00005, TG2-01169]
- Ovarian Cancer Research Fund
- Stewart and Lynda Resnik Prostate Cancer Foundation
- Stein/Oppenheimer Clinical Transitional Seed Grant
- DOD [PCO31130]
- NCI [UO1 CA84128-06, RO1 CA107166]
The Polycomb group transcriptional repressor Bmi-1 is often upregulated in prostate cancer, but its functional roles in prostate stem cell maintenance and prostate cancer are unclear. Loss- and gain-of-function analysis in a prostate sphere assay indicates that Bmi-1 expression is required for self-renewal activity and maintenance of p63(+) stem cells. Loss of Bmi-1 blocks the self-renewal activity induced by heightened beta-catenin signaling, suggesting that Bmi-1 is required for full activity of another self-renewal pathway. In vivo, Bmi-1 expression is necessary for normal prostate tubule regeneration. Altered self-renewal and proliferation through Bmi-1 modulation diminishes the susceptibility of prostate cells to transformation. In an in vivo prostate regeneration system, Bmi-1 inhibition protects prostate cells from FGF10-driven hyperplasia and slows the growth of aggressive Pten-deletion-induced prostate cancer. We conclude that Bmi-1 is a crucial regulator of self-renewal in adult prostate cells and plays important roles in prostate cancer initiation and progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据